The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.
Health care providers can take steps to protect patients targeted by ICE, ensuring that patients retain their privacy and ...
HealthDay News — For patients with desmoplastic melanoma, neoadjuvant treatment with pembrolizumab, a programmed death-1 (PD-1) immune checkpoint inhibitor, results in a pathological complete response ...
The FDA grants Fast Track designation to sonelokimab for moderate to severe palmoplantar pustulosis, a chronic inflammatory skin disease.
Though SE was the most effective therapy for Bowen disease, the risk for recurrence with 5-FU and MAL-PDT was negligible.
The 2025 to 2026 season has had an unusually highest rate of influenza hospitalizations and deaths among children.
The number of live births in the US decreased while the racial and ethnic makeup of births changed from 2016 to 2024.
South Texas Family Residential Center has confirmed 2 cases of measles among the 11000 adults and children detained there.
In patients experiencing refractory ischemic digital complications from systemic sclerosis or other diseases, BTX injections are safe and effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results